BALA CYNWYD, Pa.--(BUSINESS WIRE)--Law Office of Brodsky & Smith, LLC announces an investigation of GW Pharmaceuticals plc (“GW Pharmaceuticals” or the “Company”) (Nasdaq: GWPH) for potential violations of federal securities laws and breaches of the GW Pharmaceuticals Board’s fiduciary duties.
Click here to learn more http://brodsky-smith.com/1049-gwph-gw-pharmaceuticals-plc.html, or call: 877-534-2590. There is no cost or obligation to you.
The investigation concerns a securities class action lawsuit commenced in the United States District Court for the Southern District of New York. The complaint alleges that: (i) the Defendants made false and misleading statements including failing to disclose that the Company lacked effective internal financial controls; (ii) the company lacked effective controls over completeness and valuation of clinical trials accruals; and (iii) as a result of the foregoing, defendants’ statements about GW Pharmaceuticals business, operations, and prospects were false and/or lacked a reasonable basis at all relevant times. Following the disclosure of these facts, shares of GW Pharmaceuticals stock declined significantly.
If you purchased shares of GW Pharmaceuticals between December 4, 2015 and January 8, 2016, and wish to discuss the investigation, or if you have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC by March 21, 2016, who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 602, Bala Cynwyd, PA 19004, by e-mail at firstname.lastname@example.org, by visiting http://brodsky-smith.com/1049-gwph-gw-pharmaceuticals-plc.html, or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and successfully recovered millions of dollars for our clients and shareholders.
Attorney advertising. Prior results do not guarantee a similar outcome.